SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 16th, 2022 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 15, 2022, between T2 Biosystems, Inc., a Delaware corporation (the “Company”), the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 16th, 2022 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANTT2 Biosystems, Inc. • August 16th, 2022 • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 15, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 15, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), up to [ ● ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of the Company’s Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
